Grp78 Heterozygosity Regulates Chaperone Balance in Exocrine Pancreas with Differential Response to Cerulein-induced Acute Pancreatitis
Overview
Authors
Affiliations
The endoplasmic reticulum (ER) is abundant in the acinar cells of the exocrine pancreas. To test the role of ER homeostasis in acute pancreatitis, we manipulated GRP78 levels, a major ER chaperone, in mice. Grp78(+/+) and (+/-) littermates were fed either a regular diet (RD) or a high-fat diet. Acinar cells were examined for ER structure by electron microscopy, and ER chaperone levels were assessed by immunoblotting. Pancreatitis was induced by cerulein injection, and multiple pathological parameters were analyzed. Grp78(+/-) mice showed decreased GRP78 expression in acinar cells. Exocrine pancreata of RD-fed Grp78(+/-) mice in an outbred C57BL/6 × 129/sv genetic background exhibited ER lumen dilation, a reduction in chaperones calnexin (CNX) and calreticulin (CRT), and exacerbated pancreatitis associated with high CHOP induction. With the high-fat diet regimen, Grp78 heterozygosity triggered GRP94 up-regulation and restoration of GRP78, CNX, and CRT to wild-type levels, corresponding with mitigated pancreatitis on cerulein insult. Interestingly, after backcrossing into the C57BL/6 background, RD-fed Grp78(+/-) mice exhibited an increase in GRP94 and levels of CNX and CRT equivalent to wild type, associated with decreased experimental pancreatitis severity. Administration of a chemical chaperone, 4-phenolbutyrate, was protective against cerulein-induced death. Thus, in exocrine pancreata, Grp78 heterozygosity regulates ER chaperone balance, in dietary- and genetic background-dependent manners, and improved ER protein folding capacity might be protective against pancreatitis.
Tang Z, Ding Y, Zhang R, Zhang M, Guan Q, Zhang L Front Endocrinol (Lausanne). 2023; 13:1056283.
PMID: 36686460 PMC: 9846251. DOI: 10.3389/fendo.2022.1056283.
Targeting Endoplasmic Reticulum Stress as an Effective Treatment for Alcoholic Pancreatitis.
Li H, Wen W, Luo J Biomedicines. 2022; 10(1).
PMID: 35052788 PMC: 8773075. DOI: 10.3390/biomedicines10010108.
Ben-Dror K, Birk R Biosci Rep. 2019; 39(5).
PMID: 30992393 PMC: 6522823. DOI: 10.1042/BSR20190054.
Ye R, Onodera T, Blanchard P, Kusminski C, Esser V, Brekken R Am J Pathol. 2019; 189(4):813-825.
PMID: 30653956 PMC: 6458522. DOI: 10.1016/j.ajpath.2019.01.002.
van Lidth de Jeude J, Spaan C, Meijer B, Smit W, Soeratram T, Wielenga M Cancer Res. 2018; 78(21):6098-6106.
PMID: 30232220 PMC: 8272399. DOI: 10.1158/0008-5472.CAN-17-3600.